(Q30437752)

English

Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study (English)

1 reference

Europe PubMed Central

17 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

gynecologic oncology

1 reference

based on heuristic

inferred from title

author name string

Kathleen M Darcy

1

1 reference

Europe PubMed Central

17 August 2017

William E Brady

2

1 reference

Europe PubMed Central

17 August 2017

John W McBroom

3

1 reference

Europe PubMed Central

17 August 2017

Jeffrey G Bell

4

1 reference

Europe PubMed Central

17 August 2017

Robert C Young

5

1 reference

Europe PubMed Central

17 August 2017

William P McGuire

6

1 reference

Europe PubMed Central

17 August 2017

R Ilona Linnoila

7

1 reference

Europe PubMed Central

17 August 2017

Denver Hendricks

8

1 reference

Europe PubMed Central

17 August 2017

Tomas Bonome

9

1 reference

Europe PubMed Central

17 August 2017

John H Farley

10

1 reference

Europe PubMed Central

17 August 2017

Gynecologic Oncology Group

11

1 reference

Europe PubMed Central

17 August 2017

language of work or name

0 references

publication date

2 October 2008

1 reference

Europe PubMed Central

17 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

17 August 2017

111

1 reference

Europe PubMed Central

17 August 2017

487-495

1 reference

Europe PubMed Central

17 August 2017

3

1 reference

Europe PubMed Central

17 August 2017

p53 and its isoforms in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

p53 alterations in human cancer: more questions than answers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

p63 and p73 in human cancer: defining the network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Telomerase in relation to expression of p53, c-Myc and estrogen receptor in ovarian tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Prognostic significance of deletion and over-expression of the p53 gene in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Twenty years of p53 research: structural and functional aspects of the p53 protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Introduction: p53--the first twenty years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

The prognostic significance of p53 expression quantitated by computerized image analysis in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

p53 mutations and expression in ovarian cancers: correlation with overall survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

The p53 tumor suppressor gene frequently is altered in gynecologic cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Prognostic significance of p53 immunostaining in epithelial ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

P53 mutation in a series of epithelial ovarian cancers from the U.K., and its prognostic significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

20 June 2018

High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

14 July 2018

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

p21 and p53 in ovarian carcinoma: their combined staining is more valuable than either alone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

Glutathione S-transferase GSTM1 and GSTT1 genotypes in ovarian cancer: association with p53 expression and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

Micrometastatic p53-positive cells in the lymph nodes of early stage epithelial ovarian cancer: prognostic significance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

p53 Protein Expression and DNA Ploidy in Common Epithelial Tumors of the Ovary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

Quantification of p53 in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

p53 expression in epithelial ovarian neoplasms: relationship to clinical and pathological parameters, Ki-67 expression and flow cytometry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2615492

26 November 2018

Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

p53 gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

Prognostic factors in early-onset epithelial ovarian cancer: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

p53 and mdm2 as prognostic indicators in patients with epithelial ovarian cancer: a multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

p53 — Master and Commander

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.08.020

7 January 2021

p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/18834621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutation and overexpression of p53 in early-stage epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18834621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18834621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18834621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18834621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression and mutation of p53 in epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18834621

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.YGYNO.2008.08.020

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30437752&oldid=1977805668"